These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 9182100

  • 41. [Molecular characterization of Pseudomonas aeruginosa isolates in Cantabria, Spain, producing VIM-2 metallo-beta-lactamase].
    Rodríguez MC, Ruiz del Castillo B, Rodríguez-Mirones C, Romo M, Monteagudo I, Martínez-Martínez L.
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):99-103. PubMed ID: 19409672
    [Abstract] [Full Text] [Related]

  • 42. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK, Mirsalehian A, Rezagholizadeh F, Jabalameli F, Taherikalani M, Emaneini M.
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N, Hiruma R, Katsu K.
    J Antimicrob Chemother; 1992 Nov; 30(5):633-41. PubMed ID: 1493980
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA, Tawfik AF, Shibl AM.
    Chemotherapy; 1995 Nov; 41(3):193-9. PubMed ID: 7656665
    [Abstract] [Full Text] [Related]

  • 51. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.
    Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R.
    Clin Infect Dis; 2000 Nov; 31(5):1119-25. PubMed ID: 11073738
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM, Choi JY, Lee JY, Kang CI, Chung DR, Peck KR, Song JH, Ko KS.
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [Abstract] [Full Text] [Related]

  • 54. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF, Liu CP, Wang NY, Shih SC.
    BMC Infect Dis; 2016 Aug 24; 16(1):444. PubMed ID: 27553962
    [Abstract] [Full Text] [Related]

  • 55. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.
    J Antimicrob Chemother; 2013 Aug 24; 68(8):1772-80. PubMed ID: 23587654
    [Abstract] [Full Text] [Related]

  • 56. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012.
    Sefraoui I, Berrazeg M, Drissi M, Rolain JM.
    Microb Drug Resist; 2014 Apr 24; 20(2):156-61. PubMed ID: 24320688
    [Abstract] [Full Text] [Related]

  • 57. Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.
    Meletis G, Vavatsi N, Exindari M, Protonotariou E, Sianou E, Haitoglou C, Sofianou D, Pournaras S, Diza E.
    Eur J Clin Microbiol Infect Dis; 2014 Feb 24; 33(2):253-8. PubMed ID: 24062236
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
    Rodríguez-Martínez JM, Poirel L, Nordmann P.
    Antimicrob Agents Chemother; 2009 May 24; 53(5):1766-71. PubMed ID: 19258272
    [Abstract] [Full Text] [Related]

  • 60. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G, Marchetti F.
    Chemotherapy; 2000 May 24; 46(4):229-34. PubMed ID: 10859428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.